The Top Late-Breaking Trials - Part 2

Anchorperson: D. Capodanno

Spokesperson: M. Leon

Summary

This session presents the latest data from pivotal late-breaking trials in interventional cardiology. Highlights include one-year results from the ADALA trial, first-in-man use of the Vivasure PerQseal Elite for large hole arterial closure, two-year outcomes of the DragonFly system in China, six-month European outcomes, and insights into hypo-attenuating leaflet thickening in balloon-expandable TAVI valves.

Presentations available when logged in:

One-year results from the ADALA trial
First-in-man use of the Vivasure PerQseal Elite for large hole arterial closure
The Pivotal study of DragonFly system: two-year outcomes in China and six months outcomes in Europe
Hypo-attenuating leaflet thickening in two balloon expandable TAVI valves

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

The Top Late-Breaking Trials - Part 2

Log in or create account for free